How many drugs treat Axial Spondyloarthritis?

Drug Landscape tracks 6 marketed treatments for Axial Spondyloarthritis (deduplicated by molecule). 0 Phase 3 candidates and 0 Phase 2 candidates are in the pipeline.

How do I subscribe to ongoing alerts?

Subscribe to /feed/disease/axial-spondyloarthritis.xml in Feedly / Inoreader. Every regulatory action, PDUFA date, or trial completion in this treatment area lands in your feed automatically.

Last reviewed 2026-06-10 · How we verify

Axial Spondyloarthritis — Treatment Landscape & Competitive Intelligence

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Axial Spondyloarthritis (disease) competitive landscape: 6 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

6 marketed 0 Phase 3 0 Phase 2 Live · 30-min refresh

Marketed treatment landscape

Approved drugs treating Axial Spondyloarthritis, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Drug	Generic	Sponsor	Class	Target	First approval
Humira	ADALIMUMAB	AbbVie	TNF blocker	Tumor Necrosis Factor-alpha (TNF-alpha)	2002-01-01
Abrilada	Adalimumab-Afzb	AbbVie	TNF blocker	Tumor necrosis factor-alpha (TNF-alpha)	2002-01-01
CYLTEZO	ADALIMUMAB-ADBM	BOEHRINGER INGELHEIM		Tumor necrosis factor
Humira	Humira	Sohag University		Tumor necrosis factor
TNF Inhibitor	tnf-inhibitor	Pfizer	Monoclonal Antibody	TNF-alpha
tumor necrosis factor inhibitors (TNFi)	tumor-necrosis-factor-inhibitors-tnfi	Pfizer	biologic	tumor necrosis factor

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

AbbVie · 2 drugs in Axial Spondyloarthritis
Pfizer · 2 drugs in Axial Spondyloarthritis
BOEHRINGER INGELHEIM · 1 drug in Axial Spondyloarthritis
Pfizer Inc. · 1 drug in Axial Spondyloarthritis
Sohag University · 1 drug in Axial Spondyloarthritis

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in Axial Spondyloarthritis:

Cite this brief

Drug Landscape (2026). Axial Spondyloarthritis — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/axial-spondyloarthritis. Accessed 2026-06-10.

Axial Spondyloarthritis full disease profile — treatment pathway, diagnostics, guidelines
Browse all CI briefs
Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing